Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,517 Cr₹1,559 Cr₹871 Cr₹1,075 Cr₹671 Cr

What is the latest Sundry Debtors ratio of GLAND PHARMA ?

The latest Sundry Debtors ratio of GLAND PHARMA is ₹1,517 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,517 Cr
Mar2024₹1,559 Cr
Mar2023₹871 Cr
Mar2022₹1,075 Cr
Mar2021₹671 Cr

How is Sundry Debtors of GLAND PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,517 Cr
-2.70
Mar2024 ₹1,559 Cr
78.87
Mar2023 ₹871 Cr
-18.93
Mar2022 ₹1,075 Cr
60.19
Mar2021 ₹671 Cr -

Compare Sundry Debtors of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹32,569.4 Cr -2% 1.8% 12.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,348.0 Cr -1.3% -1.8% -12.6% Stock Analytics
DIVIS LABORATORIES ₹158,840.0 Cr -2% -4.2% 11% Stock Analytics
CIPLA ₹124,222.0 Cr -2.6% -4% -6.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,346.0 Cr 1.4% -1.5% 5.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,437.0 Cr -1.8% 1.1% -0.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2%

1.8%

12.4%

SENSEX

-1.2%

0.5%

-1.8%


You may also like the below Video Courses